Recombinant Respiratory Syncytial Viruses Lacking the C-Terminal Third of the Attachment (G) Protein Are Immunogenic and Attenuated In Vivo and In Vitro

The design of attenuated vaccines for respiratory syncytial virus (RSV) historically focused on viruses made sensitive to physiologic temperature through point mutations in the genome. These prototype vaccines were not suitable for human infants primarily because of insufficient attenuation, genetic...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Elliott, Matthew B., Pryharski, Karin S., Yu, Qingzhong, Parks, Christopher L., Laughlin, Todd S., Gupta, C. Kanta, Lerch, Robert A., Randolph, Valerie B., LaPierre, Natisha A., Heers Dack, Kristen M., Hancock, Gerald E.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Microbiology 2004
الموضوعات:
Pathogenesis and Immunity
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC415824/
https://ncbi.nlm.nih.gov/pubmed/15140975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.78.11.5773-5783.2004
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة